Carmel Pharma Introduces the Next Evolution of PhaSeal
Today, Carmel Pharma, Inc. introduces the Injector Luer Lock N35 with ErgoMotion™ during the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV.
Las Vegas, NV, December 03, 2007 --(PR.com)-- Carmel Pharma, Inc. introduces the Injector Luer Lock N35 with ErgoMotion™ during the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV.
This new component employs the innovative and unique technology of ErgoMotion™ - one swift motion to provide easy, access during drug preparation and administration when handling hazardous drugs, and is exclusive to the PhaSeal System. Additional benefits include the same dry, leakproof connections that you’ve come to trust with PhaSeal, a single-handed grip and built-in locking mechanism to make your job safer and easier.
To see a live demonstration of the Injector Luer Lock N35 with ErgoMotion™, stop by Carmel Pharma’s booth #1927.
With over 14 peer-reviewed, independent studies currently available, PhaSeal has been distinguished by prominent thought leaders as the “Gold Standard” in the safe handling arena and is the only clinically proven closed-system drug transfer device available today. The System consists of an Expansion Chamber that captures aerosols and vapors while equalizing the pressure in the vial, a Double membrane that ensures dry, leakproof connections, and a Needle-Safe Design that enables the retrieval of all the drug from the vial.
The PhaSeal System is manufactured in Gothenburg, Sweden and is distributed from its U.S. affiliate office in Columbus, OH. PhaSeal has been in use in the U.S. since 2000 and has been implemented in over 500 cancer centers, oncology practices, specialty pharmacies in the United States, including M.D. Anderson in Houston, TX, Texas Children’s and UCSF. If you have questions regarding the PhaSeal System or Carmel Pharma, Inc., please contact Christine Crooks, Director of Marketing at 1-866-487-9250 ext.202, or online at www.phaseal.com.
###
This new component employs the innovative and unique technology of ErgoMotion™ - one swift motion to provide easy, access during drug preparation and administration when handling hazardous drugs, and is exclusive to the PhaSeal System. Additional benefits include the same dry, leakproof connections that you’ve come to trust with PhaSeal, a single-handed grip and built-in locking mechanism to make your job safer and easier.
To see a live demonstration of the Injector Luer Lock N35 with ErgoMotion™, stop by Carmel Pharma’s booth #1927.
With over 14 peer-reviewed, independent studies currently available, PhaSeal has been distinguished by prominent thought leaders as the “Gold Standard” in the safe handling arena and is the only clinically proven closed-system drug transfer device available today. The System consists of an Expansion Chamber that captures aerosols and vapors while equalizing the pressure in the vial, a Double membrane that ensures dry, leakproof connections, and a Needle-Safe Design that enables the retrieval of all the drug from the vial.
The PhaSeal System is manufactured in Gothenburg, Sweden and is distributed from its U.S. affiliate office in Columbus, OH. PhaSeal has been in use in the U.S. since 2000 and has been implemented in over 500 cancer centers, oncology practices, specialty pharmacies in the United States, including M.D. Anderson in Houston, TX, Texas Children’s and UCSF. If you have questions regarding the PhaSeal System or Carmel Pharma, Inc., please contact Christine Crooks, Director of Marketing at 1-866-487-9250 ext.202, or online at www.phaseal.com.
###
Contact
Carmel Pharma, Inc.
Christine Crooks
866-487-9250
www.carmelpharma.com
Christine Crooks
866-487-9250
www.carmelpharma.com
Contact
Categories